LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹5.24 Cr | ₹1.90 Cr | ₹1.77 Cr | ₹8.95 Cr | ₹79 Cr |
What is the latest Cash Flow from Operating Activities ratio of LYKA LABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹5.24 Cr |
| Mar2025 | ₹1.90 Cr |
| Mar2024 | ₹1.77 Cr |
| Mar2023 | ₹8.95 Cr |
| Mar2022 | ₹79 Cr |
How is Cash Flow from Operating Activities of LYKA LABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.24 Cr | 176.09 | |
| Mar2025 | ₹1.90 Cr | 7.11 | |
| Mar2024 | ₹1.77 Cr | -80.20 | |
| Mar2023 | ₹8.95 Cr | -88.70 | |
| Mar2022 | ₹79 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹269.5 Cr | -0.6% | 26.9% | -26.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -0.6% |
26.9% |
-26.8% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses